Vestal Point Capital, LP

Holdings History for Bicara Therapeutics Inc. - Common Stock, par value $0.0001 per share (BCAX)

Symbol: BCAX on Nasdaq
Investment type: Equity / Common Stock, par value $0.0001 per share
Latest Disclosed Shares Owned: 5,000,000 shares
Security Ownership %: 9.2%

Shares, Excluding Options vs Price

Value, Excluding Options

Vestal Point Capital, LP ownership in Bicara Therapeutics Inc. Common Stock, par value $0.0001 per share (BCAX)

14 Aug 2025 - Vestal Point Capital, LP has filed an SCHEDULE 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 5,000,000 shares of Bicara Therapeutics Inc. Common Stock, par value $0.0001 per share (BCAX). This represents 9.2% ownership of the company. In their previous filing dated 15 May 2025, Vestal Point Capital, LP had reported owning 2,768,975 shares, indicating an increase of +81%. .

Reporting Name	Ownership %	Change	Value $	Shares owned	Change	Activity %	Price	Form	Report date	Filing time
Vestal Point Capital, LP	9.2%	+82%	$59,550,000	5,000,000	+2,231,025	+81%	$11.91	13G/A	30 Jun 2025	14 Aug 2025, 15:57
Vestal Point Capital, LP	5.1%		$28,797,340	2,768,975			$10.40	13G	31 Mar 2025	15 May 2025, 16:13

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
30 Sep 2025	3.7%	+0.07%	$80,529,000	5,100,000	+100,000	+2%	$15.79	Q3 2025
30 Jun 2025	2.4%	+1.1%	$46,450,000	5,000,000	+2,231,025	+81%	$9.29	Q2 2025
31 Mar 2025	2.6%	+1.9%	$36,079,744	2,768,975	+2,058,975	+200%	$13.03	Q1 2025
31 Dec 2024	0.73%	+0.29%	$12,368,200	710,000	+285,000	+67%	$17.42	Q4 2024
30 Sep 2024	0.85%	+0.85%	$10,824,750	425,000	+425,000	NEW	$25.47	Q3 2024

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.